Naoxintong Capsule

DRUG4 trials

Sponsors

China Academy of Chinese Medical Sciences, Xiaofei Yu, Chinese Academy of Medical Sciences, Fuwai Hospital, Chen Xiangmei

Conditions

Atherosclerotic Cardiovascular DiseaseDiabetic NephropathyIschemic Stroke

Phase 4

Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke

CompletedNCT01762163

China Academy of Chinese Medical SciencesIschemic Stroke

Start: 2013-10-31End: 2016-10-31Updated: 2016-10-12

Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM

CompletedNCT02334969

Xiaofei YuIschemic Stroke

Start: 2016-04-30End: 2018-08-30Updated: 2018-11-19

Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD

Not yet recruitingNCT07698223

Chen XiangmeiDiabetic Nephropathy

Start: 2027-03-01End: 2028-12-30Target: 410Updated: 2026-07-13

Unknown Phase

A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One

Chinese Academy of Medical Sciences, Fuwai HospitalAtherosclerotic Cardiovascular Disease

Start: 2022-12-31End: 2025-06-30Target: 80Updated: 2022-05-20

Related Papers

Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial.

2022-10-1711 citations